Rep 3.0 — how AI is re-writing the healthcare sales playbook

Sales Rep 3.0 is attracting attention, but what does it mean in practice? Following the move from spreadsheets to CRM systems, AI brings an opportunity to connect healthcare sales and marketing more closely. The rep could increasingly become an “orchestrator” of customer engagement, combining personal relationships with insights from across the organisation. Better pre-call preparation, coordinated follow-up and less administration could give representatives more time for relevant customer conversations. Bringing sales and marketing together also creates opportunities to engage customers the field force does not routinely reach. Mike Brotherston and Aldrin Fernandes discuss how AI could augment the rep’s role, why cross-functional collaboration matters, and how organisations can build on existing technology. They explore the importance of good data and tools that representatives actually use, and how businesses of different sizes can choose opportunities that match their priorities, budgets and readiness.

Sources

Supporting research and background reading; these sources are not necessarily quoted in the recording.

1. McKinsey & Company — Demystifying the omnichannel commercial model for pharma companies in Asia (2022). Explores analytics-enabled customer engagement, cross-functional working and adoption in pharma, with an emphasis on Asia.
2. Gartner — Sales organisations providing AI-enabled next-best actions are 2.6 times more likely to achieve commercial growth (2026). Broader sales research, not healthcare-specific; reports an association rather than proof that AI caused growth.
3. Fickweiler, Fickweiler and Urbach — Interactions between physicians and the pharmaceutical industry: a systematic review (2017). Background on industry interactions and prescribing behaviour, rather than evidence of AI effectiveness.